VitriVax
Boulder, CO
VitriVax is a biotech startup that develops a vaccine formulation platform. VitriVax's proprietary technology, created at the University of Colorado with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally. VitriVax is headquartered in Boulder, Colorado.
vitrivaxbio.comCompany Details
Founded
- 2017
Employees
- Between 20 - 50 employees
Raised
- $35,750,000
Headquarters Location
- Boulder, CO
Public
- No
Acquired
- No
CEO
Romulo Colindres
Founders
- Robert GarceaTheodore Randolph
Company Collections
These are collections VitriVax is a part of. Click on the collection name to view similar companies.
VitriVax's Industries
VitriVax Headquarters Location
Total Amount Raised: $35,750,000
VitriVax Funding Rounds
Series B
$17,250,000
Series B Investors
Adjuvant CapitalRA Capital ManagementGrant
$9,900,000
Grant Investors
Bill & Melinda Gates FoundationGrant
$3,600,000
Grant Investors
Bill & Melinda Gates FoundationGrant
$5,000,000
Grant Investors
Bill & Melinda Gates Foundation
VitriVax Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on VitriVax.